Hypertension and diabetes control along the HIV care cascade in rural South Africa.
Adult
Aged
Anti-Retroviral Agents
/ therapeutic use
Blood Glucose
/ metabolism
Blood Pressure
Cohort Studies
Comorbidity
Diabetes Mellitus
/ epidemiology
Female
HIV Infections
/ drug therapy
HIV-1
/ genetics
Humans
Hypertension
/ epidemiology
Longitudinal Studies
Male
Middle Aged
Patient Acceptance of Health Care
/ statistics & numerical data
Rural Population
/ statistics & numerical data
South Africa
/ epidemiology
Viral Load
/ drug effects
ART
HIV care cascade
diabetes
health systems
hypertension
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
19
04
2018
accepted:
02
11
2018
entrez:
28
3
2019
pubmed:
28
3
2019
medline:
29
1
2020
Statut:
ppublish
Résumé
Participation in antiretroviral therapy (ART) programmes has been associated with greater utilization of care for hypertension and diabetes in rural South Africa. The objective of this study was to assess whether people living with HIV on ART with comorbid hypertension or diabetes also have improved chronic disease management indicators. The Health and Aging in Africa: a longitudinal study of an INDEPTH Community in South Africa (HAALSI) is a cohort of 5059 adults >40 years old. Enrollment took place between November 2014 and November 2015. The study collected population-based data on demographics, healthcare utilization, height, weight, blood pressure (BP) and blood glucose as well as HIV infection, HIV-1 RNA viral load (VL) and ART exposure. We used regression models to determine whether HIV care cascade stage (HIV-negative, HIV+ /No ART, ART/Detected HIV VL, and ART/Undetectable VL) was associated with diagnosis or treatment of hypertension or diabetes, and systolic blood pressure and glucose among those with diagnosed hypertension or diabetes. ART use was measured from drug level testing on dried blood spots. Compared to people without HIV, ART/Undetectable VL was associated with greater awareness of hypertension diagnosis (adjusted risk ratio (aRR) 1.18, 95% CI: 1.09 to 1.28) and treatment of hypertension (aRR 1.24, 95% CI: 1.10 to 1.41) among those who met hypertension diagnostic criteria. HIV care cascade stage was not significantly associated with awareness of diagnosis or treatment of diabetes. Among those with diagnosed hypertension or diabetes, ART/Undetectable VL was associated with lower mean systolic blood pressure (5.98 mm Hg, 95% CI: 9.65 to 2.32) and lower mean glucose (3.77 mmol/L, 95% CI: 6.85 to 0.69), compared to being HIV-negative. Participants on ART with an undetectable VL had lower systolic blood pressure and blood glucose than the HIV-negative participants. HIV treatment programmes may provide a platform for health systems strengthening for cardiometabolic disease.
Identifiants
pubmed: 30916897
doi: 10.1002/jia2.25213
pmc: PMC6436499
doi:
Substances chimiques
Anti-Retroviral Agents
0
Blood Glucose
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25213Subventions
Organisme : Wellcome Trust
ID : 058893/Z/99/A
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : K43 TW010698
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124389
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009775
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI112339
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068634
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD084233
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068636
Pays : United States
Informations de copyright
© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
BMC Med. 2014 Jul 29;12:125
pubmed: 25070128
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S40-53
pubmed: 25117960
BMC Public Health. 2017 Feb 17;17(1):206
pubmed: 28212629
PLoS One. 2016 May 27;11(5):e0156309
pubmed: 27232186
J Hypertens. 2017 Jul;35(7):1345-1352
pubmed: 28267038
PLoS One. 2015 Jul 31;10(7):e0133255
pubmed: 26230949
PLoS One. 2012;7(8):e43400
pubmed: 22916256
Glob Heart. 2016 Dec;11(4):403-408
pubmed: 27938826
J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):561-567
pubmed: 28696346
Lancet Diabetes Endocrinol. 2018 Jan;6(1):7-9
pubmed: 28320585
PLoS One. 2012;7(10):e47761
pubmed: 23082211
Lancet Diabetes Endocrinol. 2017 Jan;5(1):14
pubmed: 28010784
PLoS One. 2014 Jan 02;9(1):e84317
pubmed: 24392124
J Gerontol B Psychol Sci Soc Sci. 2017 Jul 01;72(4):665-679
pubmed: 28369527
Lancet. 2016 Feb 20;387(10020):811-6
pubmed: 26299185
Lancet Diabetes Endocrinol. 2016 Jul;4(7):549-50
pubmed: 27290621
Int J Epidemiol. 2018 Jun 1;47(3):689-690j
pubmed: 29325152
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e9-e17
pubmed: 27926667
Lancet Diabetes Endocrinol. 2016 Jan;4(1):72-84
pubmed: 26548379
Int J Epidemiol. 2012 Aug;41(4):988-1001
pubmed: 22933647
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):396-402
pubmed: 27171743
J Int AIDS Soc. 2019 Mar;22(3):e25213
pubmed: 30916897